Hapvida and Intermedica Get Final Antitrust Approval for Merger

Jan. 4, 2022, 4:52 PM UTC

Brazil antitrust regulator known as Cade issued a final decision approving the merger between Hapvida and Intermedica without remedies, both companies said in filings.

  • Closing of the transaction is expected to take place early in February
  • Intermedica said it will work with Hapvida to set up a schedule for steps to be completed until the closing of the deal
  • NOTE: Brazil Regulator Backs Hapvida-Notre Dame Deal Without Remedies

To see the source of this information click here

Original Story:

Hapvida e Intermédica recebem aprovação final do Cade

To contact the translator on this story:
Caroline Aragaki in Sao Paulo at ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.